En Es
Categories

HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medical laboratories. The company’s automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals.
Products Covid-19NewsSummary
Close

Covid-19 HORIBA Medical

Clinical Laboratory

SARS-CoV-2 (orf 1ab) Premix Reagent
POCKIT Central SARS-CoV-2 Premix Reagent

The POCKIT Central SARS-CoV-2 (orf 1ab) Premix Reagent is an in-vitro diagnostic molecular assay targeting the orf 1ab gene for the qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oropharyngeal swab samples from patients suspected of SARS-CoV-2 infection (COVID-19) during the acute phase. The fully CE/VD accredited assay is intended for use with the POCKIT Central PCR system and uses gold-standard iiPCR technology to provide confidence and precision-analysis within a fast turnaround time of 85 minutes.
More details
Close

News of HORIBA Medical

HORIBA Acquires MedTest Dx and Pointe Scientific to Expand Laboratory Chemistry Offerings

03 Feb 2021
HORIBA Acquires MedTest Dx and Pointe Scientific to Expand Laboratory Chemistry Offerings
HORIBA, Ltd. (Kyoto, Japan) has acquired MedTest Holdings, Inc. (Canton, MI, USA), composed of MedTest Dx, Inc., Pointe Scientific, Inc., Clinitox Diagnostix, Inc., and Medical Laboratory Solutions, Inc.).
Read More
Close

About HORIBA Medical

HORIBA ABX designs, develops and distributes worldwide, in vitro diagnostic systems for biological analysis in medical laboratories. The company’s automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals.
FaceBook Twitter Google+ Linked in
SARS-CoV-2 (orf 1ab) Premix Reagent

SARS-CoV-2 (orf 1ab) Premix Reagent

Model: POCKIT Central SARS-CoV-2 Premix Reagent
Request Information

Description:

The POCKIT Central SARS-CoV-2 (orf 1ab) Premix Reagent is an in-vitro diagnostic molecular assay targeting the orf 1ab gene for the qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oropharyngeal swab samples from patients suspected of SARS-CoV-2 infection (COVID-19) during the acute phase.
Read More

Full Description Features Specifications

Description

The POCKIT Central SARS-CoV-2 (orf 1ab) Premix Reagent is an in-vitro diagnostic molecular assay targeting the orf 1ab gene for the qualitative detection of severe acute respiratory coronavirus 2 (SARS-CoV-2) RNA in oropharyngeal swab samples from patients suspected of SARS-CoV-2 infection (COVID-19) during the acute phase. The fully CE/VD accredited assay is intended for use with the POCKIT Central PCR system and uses gold-standard iiPCR technology to provide confidence and precision-analysis within a fast turnaround time of 85 minutes. Request Information

Features

• Validated for COVID-19 testing by the UK's Department of Health and Social Care (DHSC)
• Proven iiPCR technology
• Sample in – Results out in 85 minutes
• Up to 8 Samples analyzed in a single run
• Fully automated walk-away molecular testing protocol
• Compact footprint – ideal for rapid on-site testing in Point of Care settings such as A&E Departments, Care Homes, Sports Clubs, GP Surgeries, Clinics, Airports, Ports, Academia, Primary Care settings
• Minimal hands-on time / minimal dexterity required
• Multiplex testing capability
• Direct display of test results on the built-in touchscreen
• Printing and exporting of results via multiple methods
• Built-in UV lamp for automatic decontamination cycle after every run
• Barcode scanning available
• Fully CE-marked and IVD accredited (analyzer and reagents)

iiPCR Technology

• Combined nucleic acid extraction, amplification and detection
• iiPCR technologies with two optical channels
• Magnetic bead-based nucleic acid extraction
• Preloaded ready-to-use cartridges
• Precise and accurate results with internal control

Testing Targets (CE-IVD)

• SARS-CoV-2 (COVID-19)
• Noravirus
• C. Difficile
• Flu A & Flu B available soon Request Information

Specifications

• Dimensions: 310mm(W) × 480mm(D) × 400mm(H)
• Weight: 21kg
• Power Supply: 100-120/200-240 V AC, 50/60 Hz, 2A
• Operation altitude: Under 5,000 meters
• Operating condition: 15-35°C,up to 80% RH
• Transportation condition: -29-50˚C, 55±20% RH
• Storage condition: 10-40˚C, 55±25%RH
• Throughput: Up to 8 samples tested within 85 minutes
• Memory: 1000 patient sample results within the built-in memory. Data exporting available.
• Screen: Built-in touchscreen interface Request Information

Send A Message To This Supplier

* Required Information
* Email
To
HORIBA Medical (SARS-CoV-2 (orf 1ab) Premix Reagent)
* Message

Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions